Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer
Condition: Advanced Epithelial Ovarian Cancer Intervention: Drug: Carboplatin/paclitaxel Sponsors: Cairo University; Misr International University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials